Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 16, Issue 11, 2009, Pages 3176-3182

  Hiwatashi, Kiyokazu ^a   Ueno, Shinichi ^a   Sakoda, Masahiko ^a   Kubo, Fumitake ^a   Tateno, Taro ^a   Kurahara, Hiroshi ^a   Mataki, Yuko ^a   Maemura, Kosei ^a   Ishigami, Sumiya ^a   Shinchi, Hiroyuki ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; SMAD4 PROTEIN;

AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SMAD4 PROTEIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 70350381535     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0614-2     Document Type: Article

References (19)

1. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D 12490959 (Pubitemid 36019639)
2. M Karin 2006 Nuclear factor-kappaB in cancer development and progression Nature 441 431 436 10.1038/nature04870 1:CAS:528:DC%2BD28XkvVyrsrw%3D 16724054 (Pubitemid 44050137)
3. LM Wakefield AB Roberts 2002 TGF-beta signaling: positive and negative effects on tumorigenesis Curr Opin Genet Dev 12 22 29 10.1016/S0959-437X(01) 00259-3 1:CAS:528:DC%2BD38XktFGmtw%3D%3D 11790550 (Pubitemid 34094985)
4. RJ Akhurst R Derynck 2001 TGF-beta signaling in cancer-a double-edged sword Trends Cell Biol 11 S44 51 1:CAS:528:DC%2BD3MXnvFGrsb8%3D 11684442
5. HJ Baek SC Lim K Kitisin W Jogunoori Y Tang MB Marshall, et al. 2008 Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis Hepatology 48 1128 1137 10.1002/hep.22460 1:CAS:528:DC%2BD1cXht1Khu77E 18704924
6. J Seoane HV Le L Shen SA Anderson J Massague 2004 Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 211 223 10.1016/S0092-8674(04)00298-3 1:CAS:528:DC%2BD2cXjsFyrurc%3D 15084259 (Pubitemid 38496241)
7. Y Wu BP Zhou 2008 New insights of epithelial-mesenchymal transition in cancer metastasis Acta Biochim Biophys Sin (Shanghai) 40 643 650 10.1111/j.1745-7270.2008.00443.x 1:CAS:528:DC%2BD1cXpvF2qsL8%3D (Pubitemid 352009085)
8. T Nitta JS Kim D Mohuczy KE Behrns 2008 Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways Hepatology 48 909 919 10.1002/hep.22397 1:CAS:528: DC%2BD1cXhtFKrsLfI 18712785
9. A Kaimori J Potter JY Kaimori C Wang E Mezey A Koteish 2007 Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro J Biol Chem 282 22089 22101 10.1074/jbc.M700998200 1:CAS:528:DC%2BD2sXotVGlsLk%3D 17513865 (Pubitemid 47195788)
10. E Bettelli Y Carrier W Gao T Korn TB Strom M Oukka, et al. 2006 Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 235 238 10.1038/nature04753 1:CAS:528:DC%2BD28XksVGns7g%3D 16648838
11. JL Langowski X Zhang L Wu JD Mattson T Chen K Smith, et al. 2006 IL-23 promotes tumour incidence and growth Nature 442 461 465 10.1038/nature04808 1:CAS:528:DC%2BD28XnsVajtbk%3D 16688182 (Pubitemid 44264796)
12. B Zhang G Rong H Wei M Zhang J Bi L Ma, et al. 2008 The prevalence of Th17 cells in patients with gastric cancer Biochem Biophys Res Commun 374 533 537 10.1016/j.bbrc.2008.07.060 1:CAS:528:DC%2BD1cXhtVSiurvK 18655770
13. C Coulouarn VM Factor SS Thorgeirsson 2008 Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2059 2067 10.1002/hep.22283 1:CAS:528:DC%2BD1cXotVagt7k%3D 18506891 (Pubitemid 351945572)
14. SK Leivonen VM Kahari 2007 Transforming growth factor-beta signaling in cancer invasion and metastasis Int J Cancer 121 2119 2124 10.1002/ijc.23113 1:CAS:528:DC%2BD2sXht1ais7fI 17849476 (Pubitemid 47585589)
15. SA Hahn M Schutte AT Hoque CA Moskaluk LT da Costa E Rozenblum, et al. 1996 DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 350 353 10.1126/science.271.5247.350 1:CAS:528:DyaK28XlsFartg%3D%3D 8553070
16. S Natsugoe C Xiangming M Matsumoto H Okumura S Nakashima H Sakita, et al. 2002 Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus Clin Cancer Res 8 1838 1842 1:CAS:528:DC%2BD38Xlt1Crtbg%3D 12060625
17. P Alhopuro H Alazzouzi H Sammalkorpi V Davalos R Salovaara A Hemminki, et al. 2005 SMAD4 levels and response to 5-fluorouracil in colorectal cancer Clin Cancer Res 11 6311 6316 10.1158/1078-0432.CCR-05-0244 1:CAS:528: DC%2BD2MXpslansLc%3D 16144935 (Pubitemid 41262962)
18. CH Stuelten MB Buck J Dippon AB Roberts P Fritz C Knabbe 2006 Smad4-expression is decreased in breast cancer tissues: a retrospective study BMC Cancer 6 25 10.1186/1471-2407-6-25 16438724
19. M Torbenson S Marinopoulos D Dang M Choti R Ashfaq A Maitra, et al. 2002 Smad4 over expression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling Hum Pathol 9 871 876 10.1053/hupa.2002.128061